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Abstract: Purpose: Nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) are
physiologically relevant gaseous neurotransmitters that are endogenously produced in mammalian
tissues. In the present study, we investigated the possibility that NO and CO can regulate the
endogenous levels of H2S in bovine isolated neural retina. Methods: Isolated bovine neural retina were
homogenized and tissue homogenates were treated with a NO synthase inhibitor, NO donor, heme
oxygenase-1 inhibitor, and/donor. H2S concentrations in bovine retinal homogenates were measured
using a well-established colorimetric assay. Results: L-NAME (300 nM–500 μM) caused a
concentration-dependent decrease in basal endogenous levels of H2S by 86.2%. On the other hand,
SNP (10–300 μM) elicited a concentration-related increase in H2S levels from 18.3 nM/mg of protein
to 65.7 nM/mg of protein. ZnPP-IX (300 nM–10 μM) caused a concentration-dependent increase in
the endogenous production of H2S whereas hemin (300 nM–20 μM) attenuated the basal levels of H2S.
Conclusion: We conclude that changes in the biosynthesis and availability of both NO and CO can
interfere with the pathway/s involved in the production of H2S in the retina. The demonstrated ability
of NO, CO and H2S to interact in the mammalian retina affirms a physiological/pharmacological role
for these gaseous mediators in the eye.
Keywords: gasotransmitters; retina; endogenous production; hydrogen sulfide; carbon monoxide;
nitric oxide
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Abbreviations: H2S: Hydrogen sulfide; CO: Carbon monoxide; NO: Nitric oxide; cAMP: cyclic
AMP; CSE: cystathionine γ-lyase; CBS: cystathionine β-synthase; L-NAME: L-nitroarginine methyl
ester; SNP: sodium nitroprusside; ZnPP-IX: zinc protoporphyrin; PAG: propargyglycine; AOAA:
aminooxyacetic acid
1.

Introduction

The presence of enzymes responsible for the biosynthesis of hydrogen sulfide (H2S) from the
amino acid, L-cysteine in mammalian tissues has stimulated a surge of interest in its potential
physiological significance in biological processes [1,2]. There is evidence that H2S can share similar
physiological and pharmacological actions with other gaseous transmitters such as nitric oxide (NO)
and carbon monoxide (CO) [3–5]. In some pathophysiological conditions, the three gaseous molecules
are present in specific concentrations in disease states such as Alzheimer’s when their endogenous
production is known to be compromised [6–8]. Although these gases possess similar features and
modes of action, H2S has been reported to exhibit a number of distinct characteristics from both NO
and CO [7]. For instance, H2S has greater water solubility and the lowest potential to penetrate lipid
bilayers, and has a different pathway that leads to its biosynthesis when compared with its two gaseous
counterparts [9]. The basal production of H2S is dependent upon the activity of two pyridoxal-5′phosphate dependent-enzymes, cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE),
whilst NO is synthesized from L-arginine by NO synthase and CO is endogenously produced from
heme by heme oxygenase [10–15]. In the presence of aspartate aminotransferase, L-cysteine can also
be converted to H2S by the enzyme, 3-mercaptopyruvate sulfur-transferase (3MST) [16–20]. Since
the physiological and pharmacological targets for H2S are analogous to NO and CO, evidence available
from literature supports an interaction between these gaseous transmitters in mammalian organs and
tissues [7,21,22]. Indeed, studies in neuronal tissues and the vasculature show that the interaction
between these gases can affect their biosynthetic pathways, as well as, induce changes in their
biological responses [23]. While H2S has been shown to alter the activity and expression of NO
producing enzyme (eNOS), there is evidence that NO substrate or donors can also modulate expression
and activity of H2S producing enzymes [3,7,24–26]. Furthermore, studies by Whiteman et al. [27]
suggest that H2S may interact with NO to form an unidentified nitrosothiol moiety, which may then
regulate physiological functions of both NO and H2S [24]. Likewise, there is compelling evidence of
an interaction between H2S and CO. H2S has been reported to play a regulatory role in CO/heme
oxygenase pathways in cardiac and pulmonary diseases [28]. Indeed, under physiological conditions,
CO/heme oxygenase and H2S/CSE pathways have been demonstrated to inhibit each other in aortic
smooth muscle cells [29]. However, it remains to be determined whether NO and CO can interact with
the pathway leading to H2S biosynthesis in the retina. The aim of the present study was, therefore, to
investigate whether inhibitors and/or activators of both NO and CO pathways can alter H2S
concentrations in the bovine isolated neural retina. Parts of the work described in this paper have been
communicated in an abstract form [30].
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2.

Materials and methods

2.1. Chemicals
Hemin, zinc protoporphyrin (ZnPP-IX), L-nitroarginine methyl ester (L-NAME), sodium
nitroprusside (SNP), aminooxyacetic acid (AOAA), ethylenediamine tetra-acetic acid solution
(EDTA), zinc acetate, ferric chloride, borate buffer (pH 11.0) and N, N-dimethyl-p-phenylenediamine
sulfate were all purchased from Sigma–Aldrich, St. Louis, MO. All reagents were freshly prepared in
distilled water, except N, N-dimethyl-p-phenylenediamine which was prepared in 7.2 M hydrochloric
acid, immediately before use in the series of experiments.
2.2. Tissue preparation
Bovine eyes were obtained from Vision Tech, Dallas, TX within 24 hours following enucleation
and transported to the laboratory on ice. An incision was made along the equator of each eye and the
vitreous humor and lens were delicately removed. The neural retinae were isolated by gentle removal
from the posterior segment of the eye and immediately immersed in ice-cold 50 mM potassium
phosphate buffer (pH 7.4). Time elapsed between animal sacrifice and tissue preparation was less than
24 hours.
2.3. Measurement of basal hydrogen sulfide production in retinal tissues
H2S production was measured using the Methylene Blue method, a widely used assay that has
been shown to produce quantifiable measurements of H2S production in mammalian tissues
comparable to data obtained using H2S probes [31–35]. The methodology employed for H2S
measurement in retinal tissues was essentially the same as previously reported by Xia et al. [36] and
Kulkarni et al. [37], with some minor modifications. In brief, isolated bovine neural retina were
homogenized in freshly prepared 50 mM ice-cold potassium phosphate buffer (pH 7.4) using a hand
held tissue grinder consisting of a pestle and mortar. The tissue homogenates (0.25 ml) were
incubated in the presence or absence of NO synthase inhibitor, L-nitroarginine methyl ester (L-NAME;
300 nM–500 μM), NO donor, sodium nitroprusside (SNP; 10–300 μM), hemoxygenase-1 inhibitor,
zinc protoporphyrin (ZnPP-IX; 300 nM–10 μM) and hemoxygenase-1 inducer, hemin (300 nM–20 μM).
The drug concentrations chosen were based on previously published reports on the pharmacological
effects of NO and CO on mammalian tissues and cells [29,37]. Incubation was carried at 37 °C for 90
min in tightly sealed eppendorf tubes for the enzymatic reaction to take place for optimum production
of H2S as reported by [36,37]. EDTA (0.125 ml; 5 mM) was injected into the reaction tubes to stop the
reaction, followed by 0.5 ml of zinc acetate (1%) and 0.5 ml of borate buffer (pH 11.0). The tubes were
sealed and then incubated at 37°C for another 30 minutes. The reaction solution was mixed with 0.5
ml of N, N-dimethyl-p-phenylenediamine sulfate (20 mM, in 7.2 M HCl) and 0.5 ml of FeCl3 (30 mM)
at 37 °C for an additional 10 minutes and then centrifuged at 5000g for 3 min. The absorbance of
resulting solution was measured at 670 nm with a spectrophotometer. The H2S concentration was
calculated against the calibration curve of standard H2S solutions (10–750 µM). The protein content
of the residual pellet after centrifugation was measured using the Bradford method.
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2.4. Data analysis
Results were expressed as nanomolar of H2S produced per milligram soluble protein. Values
given are arithmetic means ± SEM. The means were determined from three separate experiments
performed in triplicates. Significance of differences between control and treatment groups were
evaluated using one-way analysis of variance (ANOVA) followed by Newman-Keul comparison test.
(Graph Pad Prism Software, San Diego, CA). The level of significance was chosen as p < 0.05.
3.

Results

3.1. Effects of L-NAME and SNP on basal concentrations of H2S
In a previous study, we showed evidence that endogenous concentrations of H2S in isolated bovine
retinae were enhanced by the substrate, L-cysteine and attenuated by inhibitors of enzymes responsible for
the biosynthesis of this gas [37]. In the present study, the NO donor, SNP (10–100 µM) caused a
concentration-dependent increase in H2S levels reaching a maximum at 100 μM (65.7 nm/mg of
protein) (Figure 1). On other hand, the NO inhibitor L-NAME (300 nM–500 μM) elicited a
concentration-dependent decrease in the basal endogenous levels of H2S from 19.2 to 2.6 nm/mg of
protein (Figure 2).
3.2. Effects of Hemin and ZnPP-IX on basal concentrations of H2S
We next investigated the pharmacological action of the heme oxygenase-1 inducer, hemin
(300 nM–20 μM) on basal concentrations of H2S in the bovine isolated retina. As shown in Figure 3,
hemin produced a concentration-dependent attenuation of basal levels of H2S from 18.9 to 3.6 nm/mg
of protein. Conversely, the heme oxygenase inhibitor, ZnPP-IX (300 nM–10 μM) significantly
increased the concentration of H2S from 19.2 to 26.5 nm/mg of protein in a concentration-dependent
manner, reaching a maximal effect at 10 μM (Figure 4).
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Figure 1. Effect of sodium nitroprusside (SNP) on endogenous levels of hydrogen
sulfide in isolated bovine retina. Vertical bars represent means ± S.E.M; n = 9. *p < 0.05
and **p < 0.01, significantly different from control.

Figure 2. Effect of L-nitroarginine methyl ester (L-NAME) on endogenous levels of
hydrogen sulfide in isolated bovine retina. Vertical bars represent means ± S.E.M; n = 9.
*p < 0.05 and **p < 0.01, significantly different from control.
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Figure 3. Effect of hemin on endogenous levels of hydrogen sulfide in isolated
bovine retina. Vertical bars represent means ± S.E.M; n = 6. *p < 0.05, **p < 0.01
and ***p < 0.001, significantly different from control.

Figure 4. Effect of zinc protoporphyrin (ZnPP-IX) on endogenous levels of hydrogen
sulfide in isolated bovine retina. Vertical bars represent means ± S.E.M; n = 6. *p < 0.05,
**p < 0.01 and ***p < 0.001, significantly different from control.
4.

Discussion

It is well-established that H2S can serve as a gaseous neurotransmitter/neuromodulator in several
mammalian tissues and organs. Indeed, there is abundant evidence that H2S is involved in several
physiological and pathophysiological processes as diverse as learning and memory, inflammation, and
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the regulation of blood pressure [6,38,39]. In the cardiovascular system, H2S has been shown to play
an important role in maintenance of vascular smooth muscle tone whereas in the central nervous system,
this gas has been found to act as a neurotransmitter/neuromodulator at synapses [40–43]. Furthermore,
H2S has also been reported to exert a neuroprotective action on neurons [11]. The observed biological
actions of H2S in the vasculature and brain have been reported to resemble those of other established
gaseous transmitters like CO and NO [44,45]. Although, studies reported in literature have focused on
understanding the physiological and pharmacological roles of H2S in cardiovascular, central nervous
and immune systems, there is limited evidence of an interaction between NO, CO and H2S in regulating
some of the observed responses in the above-named systems [8]. In the eye, changes in cyclic GMP
levels have been reported due to an interaction between these gaseous transmitters in the salamander
retina and the rabbit ophthalmic artery [46,47]. In the present study, we investigated the possibility
that activation or inhibition of pathways involved in NO and CO biosynthesis can alter basal
endogenous levels of H2S in the bovine isolated retina.
There is evidence that in the cardiovascular and central nervous systems, nitric oxide synthase
(NOS) substrates or NO donors can up-regulate the expression or activity of H2S producing
enzymes [48–51]. Other investigators also report that L-arginine can attenuate pulmonary artery
pressure by augmenting the expression and activity of CSE mRNA in lung tissue [52]. Furthermore,
there is evidence suggesting that a synergistic interaction exists between NO and H2S in regulating
vascular function [53–56]. In the present study, we measured endogenous levels of H2S in the presence
of NO donor, SNP. The incubation time period for optimal production of endogenous basal levels of
H2S was previously established in our laboratory [37]. We found that SNP increased the basal
endogenous levels of H2S suggesting that increased NO availability can regulate the production of this
gas in the retina. We also observed that at a high concentration of SNP (300 µM) the basal endogenous
levels of H2S was decreased, suggesting that NO may also have the ability to inhibit H2S production.
The precise mechanism for this effect is not clear. However, it may be due to the fact that at high
concentrations of SNP, the NO generated binds to CBS and thus has the potential to inhibit its activity
and therefore the generation of H2S. Despite this, our observations correlate well with studies in the
vasculature depicting the ability of SNP to increase the biosynthesis of H2S [48–50]. Indeed, there
is evidence that in the presence of NO, the pharmacological actions of H2S are significantly
enhanced [8,56]. The ability of NO to stimulate H2S production may be due to an augmented activity
of enzymes responsible for the biosynthesis of H2S by the NO-induced S-nitrosylation of their cysteine
residues or indirect stimulation of CSE by NO through an increase in the activity of cyclic GMPdependent kinases [8,35,45]. Taken together, these results indicate that NO may interact directly with
CBS and CSE to augment H2S production. To confirm the nature of this interaction, we investigated
the effect of an inhibitor of NO synthase, L-NAME on endogenous H2S production. Our results
demonstrate that L-NAME reduced basal H2S levels suggesting that endogenously generated NO can
modulate the basal levels of H2S presumably through an interaction with pathways involved in H2S
production. Other studies in the vasculature have also reported a similar inhibitory effect of L-NAME
on H2S production and activity [8,53]. The exact mechanisms +that underlie H2S and NO interactions
in the neural retinae are unknown and merits further investigation.
In addition to studying the possible interaction between NO and H2S, we designed experiments
to determine whether changes in CO production can regulate the endogenous levels of H2S in neural
retinae. In these studies, hemin and ZnPP-IX were employed as an inducer and an inhibitor of heme
oxygenase, respectively [57,58]. We found that hemin caused a concentration-related decrease in basal
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levels of H2S. In contrast, ZnPP-IX elicited a concentration-dependent increase in endogenous H2S
levels. Our results reveal that increasing CO production led to a decrease in basal concentrations of
H2S whereas, inhibiting CO biosynthesis can cause an elevation of H2S levels. These results correlate
well with studies reported by Jin et al. [29] who showed that endogenous CO down-regulates the H2S
production in aortic smooth muscle cells. A similar interaction between these two gaseous transmitters
has also been observed in the carotid body, the liver, and the microvasculature of the brain [59–61]. It
appears that in the bovine retina, reduction of CO biosynthesis removes a tonic inhibitory action of
this gas on H2S production. It is, however, unclear how CO acts to regulate the biosynthesis of H2S in
the retina.
Previous evidence from our laboratory and others suggests that crosstalk between the three
gasotransmitters exists in ocular tissues [46,47,62–64]. In the salamander retina, all three gases were
found to play interactive roles in modulating retinal cGMP signaling, as NO and CO significantly
increased cGMP-like immunoreactivity (cGMP-LI) both alone and synergistically [46]. NaHS was
found to inhibit the NO-induced increase in cGMP-LI from the inner nuclear layer to the ganglion cell
layer, indicating an interaction in these three gases in the retina [46]. H2S was found to enhance
phenylephrine induced tone in the rabbit ophthalmic artery, while CO and NO both caused
concentration dependent relaxations [47]. The mechanisms behind these pharmacological actions may
be attributed to the gaseous transmitters’ ability to modulate cGMP production in the rabbit model, as
H2S was found to reduce cGMP levels and prevent a NO induced increase in cGMP [47]. The relaxing
effect of hydrogen sulfide donors on smooth muscles in both bovine and porcine ocular tissues have
also been found to be dependent, at least in part, on the presence and activity of nitric oxide [62–64].
Taken together, these studies implicate an interactive regulatory role of these gaseous modulators in
ocular tissues.
In conclusion, changes in the biosynthesis and availability of both NO and CO can interfere with
the pathway/s involved in the production of H2S in the bovine isolated retina. The present observation
that basal levels of H2S can be altered by manipulation of pathways involved in NO/CO production is
of great interest and merits further investigation.
Despite these novel findings, the results should be interpreted with prudence due to limitation of
our study protocol. For instance the colorimetric methodology used for determination of endogenous
production of H2S is based on the assumption that tissue concentration of sulfide are high, and hence
it does not distinguish between acid labile sulfur stores or bound sulfane stores. In addition the enzyme
inhibitors being used in the studies are pyridoxal-5’ phosphate (PLP) enzyme inhibitors that are not
specific for H2S biosynthesizing enzymes, CBS and CSE as these enzymes are known to be involved
in other cellular processes in mammals. Thus, it would be worthwhile to investigate whether H2S
synthesis alters the expression of these biosynthesizing enzymatic proteins. Despite the limitations of
the study protocol, the results provide a basis for future studies on the role of H2S in the posterior
segment of the eye.
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